# An ingestible device for automated sampling and location tracing in gastrointestinal tract

## TL;DR

A new ingestible capsule can collect fluid samples from different parts of the gastrointestinal tract and determine their location automatically.

## Contribution

The development of an ingestible capsule with automated sampling and location tracing in the GI tract.

## Key findings

- The capsule successfully collected samples from the stomach, small intestine, and colon in canine models.
- Inertial measurements within the capsule correlated with the location of sampled regions.
- The device was verified through in vitro and in vivo tests.

## Abstract

Fluids sampled from the gastrointestinal (GI) tract are of interest for evaluating the bioequivalence of oral medications, and more generally for evaluating GI-related diseases, and for profiling the individual gut microbiome. Existing options for capturing multiple fluid samples from specific locations in the GI tract are limited and invasive, particularly for the small intestine. Here, we report the development of an ingestible capsule for the collection of multiple fluid samples along the GI tract; we additionally report the use of data from sensors within the capsule to determine the sampling regions. The capsule has an ingestible size of Φ14 × 42 mm3. Within this volume, it includes three separate cartridges that capture and retain samples within capillaries; a stepper motor for positioning the sampling cartridges at a sampling port; a 3-axis accelerometer that enables a new method of correlating sample location; a microcontroller with wireless communication and sensor data storage capabilities; and batteries to power the device. We describe in vitro characterization and in vivo tests performed with canine models that have successfully verified the capabilities of the capsule. Fluid samples from the stomach, small intestine, and colon regions of the GI tract are identified by inertial measurements taken within the capsule, and correlated to measurements of the concentration of mesalamine (a drug used for testing) and the bile salt profile in each region, respectively.